Two Sigma Investments’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-446
| Closed | -$7.55K | – | 3242 |
|
|
2024
Q3 | $7.55K | Buy |
+446
| New | +$7.55K | ﹤0.01% | 2988 |
|
|
2024
Q1 | – | Sell |
-596
| Closed | -$141K | – | 3067 |
|
|
2023
Q4 | $141K | Sell |
596
-545
| -48% | -$129K | ﹤0.01% | 2814 |
|
|
2023
Q3 | $171K | Sell |
1,141
-756
| -40% | -$113K | ﹤0.01% | 2594 |
|
|
2023
Q2 | $330K | Sell |
1,897
-1,809
| -49% | -$315K | ﹤0.01% | 2414 |
|
|
2023
Q1 | $467K | Buy |
3,706
+1,522
| +70% | +$192K | ﹤0.01% | 2160 |
|
|
2022
Q4 | $662K | Sell |
2,184
-99
| -4% | -$30K | ﹤0.01% | 1842 |
|
|
2022
Q3 | $126K | Sell |
2,283
-940
| -29% | -$51.9K | ﹤0.01% | 2146 |
|
|
2022
Q2 | $193K | Sell |
3,223
-985
| -23% | -$59K | ﹤0.01% | 2106 |
|
|
2022
Q1 | $480K | Sell |
4,208
-1,895
| -31% | -$216K | ﹤0.01% | 1996 |
|
|
2021
Q4 | $879K | Buy |
6,103
+1,118
| +22% | +$161K | ﹤0.01% | 1716 |
|
|
2021
Q3 | $1.09M | Buy |
4,985
+2,729
| +121% | +$598K | ﹤0.01% | 1653 |
|
|
2021
Q2 | $523K | Sell |
2,256
-6,407
| -74% | -$1.49M | ﹤0.01% | 1941 |
|
|
2021
Q1 | $2.61M | Buy |
8,663
+910
| +12% | +$274K | 0.01% | 1134 |
|
|
2020
Q4 | $2.92M | Buy |
7,753
+4,687
| +153% | +$1.76M | 0.01% | 930 |
|
|
2020
Q3 | $941K | Sell |
3,066
-1,664
| -35% | -$511K | ﹤0.01% | 1195 |
|
|
2020
Q2 | $1.78M | Buy |
4,730
+1,973
| +72% | +$742K | 0.01% | 922 |
|
|
2020
Q1 | $629K | Buy |
2,757
+749
| +37% | +$171K | 0.01% | 1163 |
|
|
2019
Q4 | $1.06M | Buy |
2,008
+768
| +62% | +$406K | ﹤0.01% | 1386 |
|
|
2019
Q3 | $534K | Buy |
+1,240
| New | +$534K | ﹤0.01% | 1433 |
|
|
2019
Q1 | – | Sell |
-161
| Closed | -$152K | – | 2243 |
|
|
2018
Q4 | $152K | Buy |
+161
| New | +$152K | ﹤0.01% | 1911 |
|
|
2018
Q1 | – | Sell |
-229
| Closed | -$384K | – | 2108 |
|
|
2017
Q4 | $384K | Buy |
+229
| New | +$384K | ﹤0.01% | 1854 |
|